Unique Ingredient Identifier 96K6UQ3ZD4 is listed as a ingredient substance
| RN | 56038-13-2 |
| EC | 259-952-2 |
| NCIT | C79882 |
| RXCUI | 1439115 |
| PUBCHEM | 71485 |
| MF | C12H19Cl3O8 |
| INCHI KEY | BAQAVOSOZGMPRM-QBMZZYIRSA-N |
| SMILES | OC[C@H]1O[C@H](O[C@]2(CCl)O[C@H](CCl)[C@@H](O)[C@@H]2O)[C@H](O)[C@@H](O)[C@H]1Cl |
UNII 96K6UQ3ZD4 SUCRALOSE is commonly included in medications in the following forms.
| Route | Dosage Form | Potency |
|---|---|---|
| BUCCAL | GUM, CHEWING | 3.5 MG |
| NASAL | SPRAY | 205.5 MCG/SPRAY |
| NASAL | SPRAY | 0.15 % |
| NASAL | SPRAY, METERED | 205.5 MCG/SPRAY |
| NASAL | SPRAY, METERED | 0.15 % |
| ORAL | FILM, SOLUBLE | 5.5 MG |
| ORAL | GRANULE | 5.4 MG |
| ORAL | GRANULE, FOR ORAL SUSPENSION | 2.33 MG |
| ORAL | LIQUID | 3 MG/1ML |
| ORAL | LOZENGE | 4 mg |
| ORAL | ORAL SOLUTION DOSAGE FORM | 2.875 mg/5mL |
| ORAL | POWDER, FOR ORAL SOLUTION | 1210 MG |
| ORAL | POWDER, FOR ORAL SOLUTION | 0.79 G/16 OZ |
| ORAL | POWDER, FOR ORAL SUSPENSION | 90 MG/1PKT |
| ORAL | POWDER, FOR SOLUTION | 34.25 MG |
| ORAL | POWDER, FOR SUSPENSION | 18 g |
| ORAL | POWDER, FOR SUSPENSION | 0.0055 g/236mL |
| ORAL | SOLUTION | 200 MG/160ML |
| ORAL | SOLUTION | 40 MG/1ML |
| ORAL | SOLUTION | 22.5 mg |
| ORAL | SOLUTION | 22.5 mg/15 mL |
| ORAL | SOLUTION, SYRUP | 4.64 MG |
| ORAL | SUSPENSION | 40 MG/5ML |
| ORAL | SUSPENSION | 6 mg/1mL |
| ORAL | SUSPENSION, EXTENDED RELEASE | 2 MG/1ML |
| ORAL | SYRUP | 1 MG/1ML |
| ORAL | TABLET | 15 MG |
| ORAL | TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE | 1.88 MG |
| ORAL | TABLET, CHEWABLE | 4 MG |
| ORAL | TABLET, EFFERVESCENT, FOR SOLUTION | 30 MG |
| ORAL | TABLET, ORALLY DISINTEGRATING | 12 MG |
| ORAL | TABLET, UNCOATED, LOZENGE | 0.76 MG |
| ORAL | TROCHE | 4 MG |
| SUBLINGUAL | TABLET | 1.5 MG |
| SUBLINGUAL | TABLET (IMMED./COMP. RELEASE), UNCOATED, BUCCAL | 0.52 MG |